Spyre Therapeutics Inc <SYRE.O>: Leerink Partners Raises Target Price to $124 From $106
SYRE•Related News
EVgo Q2 revenue beats on increased network throughput
EVGO•
Barclays Bank launches debt issuance programme for notes with minimum €100,000 denomination
BCS•
Workiva Inc. <WK.N>: Raymond James cuts target price to $80 from $85
WK•
Advanced Micro Devices <AMD.O>: Morgan Stanley raises target price to $465.00 from $410.00
AMD•
Griffon FY26 Q3 operating income swings to USD 115.5 million; revenue rises 7% to USD 481.4 million
GFF•